Semnur Pharmaceuticals Inc (SMNR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SMNR Annual Balance Sheets →
This balance sheet overview for Semnur Pharmaceuticals Inc spans from Jun 30 2025 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.04
Cash & Short-term Investments0.00
Other Current Assets0.05
Prepaid Expense, Current AS1.10
Total Current Assets1.19
Equipment/Property/Plant Net0.78
Other Assets, Noncurrent0.00
Total Assets1.94
Liabilities
Accounts Payable, Current AC6.92
Accrued Liabilities, Current AC1.65
Notes Payable, Current NO2.11
Other Liabilities, Current0.00
Total Current Liabilities10.67
Long-term debt6.06
Total Long-term Debt6.06
Other liabilities, Noncurrent14.89
RelatedPartyLoansNoncurrent16.92
Total Liabilities31.62
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock255.03
Retained Earnings / Accumulated Deficit-284.72
Other Equity0.00
Common Stockholder's Equity-29.67
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.00
Total Stockholder's Equity-29.67
Liabilities & Stockholder's Equity1.94
4 historic quarters locked

Sign in to unlock the full Semnur Pharmaceuticals Inc balance sheet history.

About Semnur Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-342594

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.